Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
South Korea flag South Korea · Delayed Price · Currency is KRW
973.00
-1,807.00 (-65.00%)
At close: Jun 24, 2025

KRX:002210 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2011FY 2010FY 2009FY 2008FY 2007
Period Ending
Dec '11 Dec '10 Dec '09 Dec '08 Dec '07
Cash & Equivalents
8,1477,3952,9255,2415,763
Short-Term Investments
774.122,2874,794405-
Trading Asset Securities
5,3248,4375,0737,9427,940
Cash & Short-Term Investments
14,24618,12012,79113,58913,703
Cash Growth
-21.38%41.66%-5.87%-0.83%45.40%
Accounts Receivable
45,27844,80647,11343,99842,912
Other Receivables
700.07420.8780.64477.531,557
Receivables
48,17146,32948,83644,82844,569
Inventory
11,17610,55412,08210,32510,173
Prepaid Expenses
77.35225.03161.69203.1997.72
Other Current Assets
1,3781,7201,9623,6231,651
Total Current Assets
75,04876,94776,20672,62270,740
Property, Plant & Equipment
30,61727,66647,70048,24828,254
Long-Term Investments
1,1601,3662,1521,8691,983
Other Intangible Assets
1,166967.72812.2758.39168.32
Long-Term Deferred Tax Assets
----1,024
Other Long-Term Assets
16,41020,661836.481,0731,249
Total Assets
124,577127,808127,906124,570103,417
Accounts Payable
12,39812,1629,4219,6769,544
Accrued Expenses
1,9762,4881,7782,0091,322
Short-Term Debt
32,16830,04623,30019,70023,400
Current Portion of Long-Term Debt
1,1278696,247337.74925.24
Current Income Taxes Payable
266.344,073-345.841,101
Current Unearned Revenue
51.06191.99---
Other Current Liabilities
2,9343,1563,0003,9512,789
Total Current Liabilities
50,92052,98643,74636,02039,080
Long-Term Debt
1,6362,7631,7586,9997,056
Pension & Post-Retirement Benefits
1,7272,1512,8532,2803,765
Long-Term Deferred Tax Liabilities
2,7083,0194,4034,331-
Other Long-Term Liabilities
7,3857,7887,1767,1167,377
Total Liabilities
64,37668,70659,93656,74757,278
Common Stock
21,12821,12821,12821,12821,128
Additional Paid-In Capital
11,26111,26111,52811,52811,528
Retained Earnings
31,91330,81419,25019,22716,115
Treasury Stock
-4,101-4,101-3,201-3,201-3,201
Comprehensive Income & Other
--19,26519,142569.62
Shareholders' Equity
60,20159,10267,97067,82346,139
Total Liabilities & Equity
124,577127,808127,906124,570103,417
Total Debt
34,93033,67731,30527,03731,381
Net Cash (Debt)
-20,685-15,557-18,514-13,448-17,678
Net Cash Per Share
-1171.40-863.57-1019.60-740.63-1016.30
Filing Date Shares Outstanding
17.6617.6618.1618.1618.16
Total Common Shares Outstanding
17.6617.6618.1618.1618.16
Working Capital
24,12823,96132,45936,60231,659
Book Value Per Share
3409.293347.023743.243735.152540.97
Tangible Book Value
59,03558,13467,15867,06445,971
Tangible Book Value Per Share
3343.243292.223698.513693.382531.70
Land
16,49413,37430,23530,2308,992
Buildings
21,21720,01825,11825,06025,506
Machinery
8,8448,4608,9118,7118,294
Construction In Progress
-95.3719.32-89.18
Updated Aug 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.